PTGX

Actualités Protagonist Therapeutics

Les meilleurs offres pour accéder les cours en temps réel en illimité
Expert
Abonnement Mensuel
Seulement
92,39 €
Trade Alert US
Abonnement Mensuel
Seulement
52,79 €
Real-time Level 1 for Canada + USA
Abonnement Mensuel
Seulement
32,99 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Protagonist Therapeutics Inc PTGX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Bas Plus Haut Ouverture Clôture Veille Dernier échange
1,49 9,03% 17,935 16,325 18,2799 16,50 16,45 19:59:00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/8/202022:09EDGARCurrent Report Filing (8-k)
06/8/202022:01PRNUSProtagonist Therapeutics Reports Second Quarter Financial..
18/6/202005:07PRNUSHepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug..
17/6/202000:05PRNUSProtagonist Therapeutics to Participate in the BMO..
09/6/202022:33EDGARAmended Statement of Ownership (sc 13g/a)
08/6/202022:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
04/6/202013:00PRNUSProtagonist Therapeutics to Present at the 25th European..
30/5/202000:21EDGARStatement of Changes in Beneficial Ownership (4)
30/5/202000:20EDGARStatement of Changes in Beneficial Ownership (4)
30/5/202000:19EDGARStatement of Changes in Beneficial Ownership (4)
30/5/202000:17EDGARStatement of Changes in Beneficial Ownership (4)
30/5/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
30/5/202000:13EDGARStatement of Changes in Beneficial Ownership (4)
29/5/202022:06EDGARCurrent Report Filing (8-k)
28/5/202013:00PRNUSProtagonist Therapeutics to Present at Two Upcoming..
22/5/202022:31EDGARStatement of Ownership (sc 13g)
13/5/202012:05EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/5/202016:54EDGARCurrent Report Filing (8-k)
12/5/202006:57PRNUSProtagonist Therapeutics, Inc. Announces Upsizing and..
11/5/202013:00EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/5/202012:59PRNUSProtagonist Therapeutics, Inc. Announces Proposed..
07/5/202023:17EDGARQuarterly Report (10-q)
07/5/202022:42EDGARCurrent Report Filing (8-k)
07/5/202022:31PRNUSProtagonist Therapeutics Reports First Quarter Financial..
07/5/202022:30PRNUSProtagonist Therapeutics Announces Initial Phase 2 Results..
04/5/202013:00PRNUSProtagonist Therapeutics to Announce First Quarter 2020..
01/5/202023:33EDGARStatement of Changes in Beneficial Ownership (4)
16/4/202023:30EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
16/4/202023:29EDGARProxy Statement (definitive) (def 14a)
16/4/202002:35PRNUSProtagonist Therapeutics Reports Granting of Inducement..
08/4/202023:47EDGARStatement of Changes in Beneficial Ownership (4)
23/3/202023:15EDGARStatement of Changes in Beneficial Ownership (4)
18/3/202021:43EDGARCurrent Report Filing (8-k)
13/3/202018:05EDGARStatement of Changes in Beneficial Ownership (4)
13/3/202000:27EDGARStatement of Changes in Beneficial Ownership (4)
10/3/202022:25EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/3/202022:19EDGARAnnual Report (10-k)
10/3/202021:06EDGARCurrent Report Filing (8-k)
10/3/202021:01PRNUSProtagonist Therapeutics Reports Fourth Quarter and Full..
02/3/202022:30PRNUSProtagonist Therapeutics to Announce Fourth Quarter and Full..
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:16EDGARStatement of Changes in Beneficial Ownership (4)
29/2/202000:15EDGARStatement of Changes in Beneficial Ownership (4)
24/2/202022:06EDGARCurrent Report Filing (8-k)
19/2/202013:00PRNUSProtagonist Therapeutics to Present at the SVB Leerink 9th..
14/2/202022:22EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202022:05EDGARAmended Statement of Ownership (sc 13g/a)
14/2/202020:40EDGARAmended Statement of Ownership (sc 13g/a)
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NASDAQ
PTGX
Protagonis..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20200807 18:14:14